Targretin and Prednisolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Targretin (bexarotene) and Prednisolone (prednisolone). Common drug interactions include disease progression among females and staphylococcal bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Targretin and Prednisolone. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Targretin?

Targretin has active ingredients of bexarotene. eHealthMe is studying from 1,064 Targretin users. Check the latest studies of Targretin.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

13 people who take Targretin and Prednisolone together, and have interactions are studied.

Targretin and Prednisolone drug interactions.

What are the common drug interactions of Targretin and Prednisolone, by gender? *:

female:

Disease progression
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)

male:

Staphylococcal bacteraemia (a bacterial infection of blood)
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Immunosuppression
Skin bacterial infection
Hypertriglyceridaemia (excess of triglycerides in the blood)
Weight decreased
Septic shock (shock due to blood infection)
Drug ineffective

What are the common drug interactions of Targretin and Prednisolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Disease progression
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)

60+:

Staphylococcal bacteraemia (a bacterial infection of blood)
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Immunosuppression
Skin bacterial infection
Hypertriglyceridaemia (excess of triglycerides in the blood)
Weight decreased
Septic shock (shock due to blood infection)
Drug ineffective

What are the existing conditions these people have? *

Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 8 people, 61.54%
Hypertriglyceridaemia (excess of triglycerides in the blood): 6 people, 46.15%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 38.46%
Immunodeficiency Disorders: 4 people, 30.77%
Skin Cancer: 2 people, 15.38%
T-Cell Lymphoma (a blood cell cancer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Targretin and Prednisolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously